Relapse Multiple Myeloma
Oncology·MeSH: Multiple Myeloma
Prevalence
17.0 / 100K
Incidence
7.0 / 100K/yr
2 drugs in development·1 company·3 clinical trials
Drug Pipeline by Phase
Phase 3(2)
Compare drugs
Frequently asked questions
How many drugs are in development for Relapse Multiple Myeloma?
BioSniper tracks 2 drugs in development for Relapse Multiple Myeloma across 1 company.
How many clinical trials target Relapse Multiple Myeloma?
There are 3 clinical trials targeting Relapse Multiple Myeloma tracked by BioSniper.
What is the prevalence of Relapse Multiple Myeloma?
The estimated prevalence of Relapse Multiple Myeloma is approximately 17.0 per 100,000 population.
Deep-dive into Relapse Multiple Myeloma
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis